CD8A and neoplasm: Moreover, we observed a higher percentage of transferred Thy1.1+CD8+ T cells in peripheral blood and spleen from Tc9 cell–treated tumor-bearing mice than those treated with Tc1 cells (Supplemental Figure 2, C and E) and less lipid ROS in circulating and splenic Tc9 cells than Tc1 cells (Supplemental Figure 2, D and F).